Abstract:Optogenetic inhibition of excitatory populations has been suggested as a novel technique for the treatment of refractory epilepsy. While this approach holds significant potential, achieving seizure suppression in animal models using optogenetics has proven challenging. This difficulty can be attributed to a suboptimal stimulation method that involves numerous complex variables. To provide insight into these parameters, the behavior of the chloride conducting opsin, GtACR2, was fitted to a mathematical description and combined with a conductance-based model of a pyramidal CA1 neuron. The resulting model was adapted to add the ability to study potassium conducting opsins and used to demonstrate that the effect of an optogenetic modulation setup is highly dependent on its parameters and the physiological conditions of the neuronal environment. Stronger inhibition is observed at higher pulse repetition frequencies and duty cycles. Furthermore, potassium conducting opsins were shown to be more stable in use than chloride conducting ones. The dependence of these observations on the opsin model fit was found to be negligible. To determine this, a simplified model (22OMs) is proposed that permits easy implementation of the experimentally derived parameters describing the opsin's opening and closing dynamics into its mathematical description. This model was also employed to determine that the impact of varying the opsin's dynamics is insignificant when the opening and closing time constants are altered by a factor between 0.5 and 2. Consequently, this study provides insights into the stimulation and physiological parameters influencing the outcome of an optogenetic inhibition approach and offers a new tool that will facilitate future research into the development of an improved optogenetic modulation protocol for seizure suppression.

A toolbox for ablating excitatory and inhibitory synapses

An Artificial Protein Modulator Reprogramming Neuronal Protein Functions

Interrogating the function of GABAA receptors in the brain with optogenetic pharmacology

Revealing Acute Consequences of Rapid Protein Elimination at Individual Synapses using Auxin-Inducible Degron 2 Technology

A photoswitchable GPCR-based opsin for presynaptic inhibition

A bistable inhibitory optoGPCR for multiplexed optogenetic control of neural circuits

Cell‐Specific Optical Control of AMPA Glutamate Receptors with a Photoswitchable Tethered Antagonist

High-efficiency optogenetic silencing with soma-targeted anion-conducting channelrhodopsins

Optogenetic control of genetically-targeted pyramidal neuron activity in prefrontal cortex

High fidelity optogenetic control of individual prefrontal cortical pyramidal neurons in vivo

Efficient optogenetic silencing of neurotransmitter release with a mosquito rhodopsin

Upconversion Nanoparticles-Based Multiplex Protein Activation to Neuron Ablation for Locomotion Regulation.

A modular toolbox for the optogenetic deactivation of transcription

Chemically Inducible Inactivation of Protein Synthesis in Genetically Targeted Neurons

Opto-chemogenetic inhibition of L-type CaV1 channels in neurons through a membrane-assisted molecular linkage

Dual-color optical activation and suppression of neurons with high temporal precision

Optogenetic polymerization and assembly of electrically functional polymers for modulation of single-neuron excitability

Targeting Light-Gated Chloride Channels to Neuronal Somatodendritic Domain Reduces Their Excitatory Effect in the Axon

An enhancer-AAV toolbox to target and manipulate distinct interneuron subtypes

Computational analysis of optogenetic inhibition of CA1 neurons using a data-efficient and interpretable potassium and chloride conducting opsin model

Visualization of synaptic inhibition with an optogenetic sensor developed by cell-free protein engineering automation.